By Admin at 13 Apr 2016

Patients with acute lymphoblastic leukemia (ALL), non-Hodgkin lymphoma and chronic lymphocytic leukemia are taking part in the trial and received an experimental “living” immunotherapy. The results have so far been “extraordinary,” according to the researchers, including among some patients that were initially given only months to live.

By Admin at 9 Nov 2015

The mosquito-borne infection malaria causes more than 1 million deaths a year, but researchers believe a protein produced by the destructive disease may have the potential to help fight cancer.